🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI
$1.62
-48.57% 1Y
P/E-0.75
52W High$3.51
52W Low$1.49
EPS (TTM)$-2.16

Company Overview

BMRA (BMRA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • May 2025 Revenue of $5.31M (-1.9% YoY); net profit $-4.97M.
  • Trailing 12 Months Year-on-year growth — revenue -1.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 0.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:0.58%
1 Year:-1.92%

Stock Price Performance

1 Year:-48.57%
6 Months:-30.77%
3 Months:-26.03%
1 Month:-5.81%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 6% of range
$1.49 $3.51
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)45.57 · Neutral
Price Performance
1M-5.81%
3M-26.03%
6M-30.77%
1Y-48.57%

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 53.9% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
-0.75
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
0.58%
Profit 5Y
-
Revenue (YoY)
-1.92%
Earnings (YoY)
-

Profitability & Returns

ROCE
-122.16%
ROE
-121.14%
ROA
-83.65%
Profit Margin
-93.64%
Op Margin
-96.72%
Gross Margin
9.38%
EPS (Latest Qtr)
$-0.44
EPS (TTM)
$-2.16

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$4.88M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
15.24%
Chg in Prom Hold
-
FII / Inst Holding
3.62%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$5.31M
EBITDA
-
Free Cash Flow
$-5.41M
Operating Cash Flow
$-3.84M
Shares Outstanding
-
Gross Margin
9.38%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Feb 2013Aug 2013Nov 2013Feb 2014Aug 2014Nov 2014Feb 2015Aug 2015Nov 2015Feb 2016Aug 2016Nov 2016Feb 2017Aug 2017Nov 2017Feb 2018Aug 2018Nov 2018Feb 2019Aug 2019Nov 2019Feb 2020Aug 2020Nov 2020Feb 2021Aug 2021Nov 2021Feb 2022Aug 2022Nov 2022Feb 2023Aug 2023Nov 2023Feb 2024Aug 2024Nov 2024Feb 2025Aug 2025Nov 2025Feb 2026
Revenue ------------------1.26M1.19M1.60M1.18M1.14M1.37M3.63M1.26M4.65M7.66M1.64M1.48M1.11M1.71M1.57M1.02M1.81M1.64M1.12M1.38M1.21M987.00K
Gross Profit 445.38K260.29K255.64K578.56K309.91K307.24K458.83K421.42K412.04K344.52K576.96K556.68K449.43K514.57K506.19K465.37K337.22K408.06K365.92K367.30K468.87K211.98K118.09K308.72K-73.43K-88.97K771.76K1.67M-55.00K352.00K120.00K412.00K325.00K-149.00K289.00K437.00K19.00K424.00K51.00K-44.00K
Operating Income -63.33K-173.77K-247.50K32.62K-224.11K-249.87K-135.54K-76.23K-209.77K-269.11K-65.63K-219.54K-317.72K-226.03K-288.74K-322.85K-454.79K-485.94K-707.25K-509.56K-489.74K-914.88K-1.90M-1.71M-2.17M-1.54M-1.13M-107.50K-2.07M-1.67M-1.65M-1.23M-1.61M-2.00M-1.37M-993.00K-1.21M-1.12M-1.37M-1.30M
Net Income -35.61K-167.71K-243.36K26.54K-219.27K-238.03K-117.19K-72.33K-66.77K-135.00K-55.42K-202.89K-304.14K-207.06K-268.66K-322.49K-451.74K-477.24K-678.75K-506.30K-485.26K-860.93K-1.89M-1.72M-2.12M-1.54M-1.13M-104.17K-2.07M-1.63M-1.65M-1.13M-1.51M-1.92M-1.32M-950.00K-1.16M2.00K-1.32M-1.31M
Diluted EPS -0.01-0.02-0.030.00-0.03-0.03-0.02-0.01-0.01-0.02-0.01-0.02-0.04-0.02-0.03-0.04-0.05-0.05-0.07-0.05-0.05-0.09-0.16-0.15-0.18-0.12-0.09-0.01-0.16-0.12-0.12-0.07-0.09-0.11-0.63-0.06-0.480.00-0.45-0.44
R&D Expense 150.18K91.26K136.79K140.18K195.71K182.09K184.63K157.99K230.21K185.27K224.25K300.96K256.72K288.58K272.44K353.56K391.78K381.40K497.10K370.47K404.85K473.28K711.50K616.56K563.97K381.54K547.93K387.10K361.00K462.00K392.00K472.00K412.00K343.00K297.00K257.00K217.00K212.00K193.00K178.00K

Profit & Loss (Annual)

Figures in USD.

Metric May 2011May 2012May 2013May 2014May 2015May 2016May 2017May 2018May 2019May 2020May 2021May 2022May 2023May 2024May 2025
Revenue 4.90M6.08M6.47M5.12M4.96M5.14M5.79M5.56M5.20M6.69M7.20M18.87M5.34M5.42M5.31M
Gross Profit 1.53M2.30M2.43M1.67M1.54M1.52M2.02M1.75M1.29M1.78M366.29K2.98M446.00K611.00K498.00K
Operating Income -132.26K505.00K514.01K-446.59K-670.60K-826.95K-954.63K-1.48M-2.41M-2.40M-7.50M-4.53M-7.22M-6.37M-5.14M
Net Income 157.45K548.43K536.96K-215.66K-331.41K-1.50M-908.56K-1.47M-2.39M-2.34M-7.45M-4.53M-7.14M-5.98M-4.97M
Diluted EPS 0.020.080.07-0.03-0.04-0.20-0.11-0.17-0.26-0.23-0.62-0.36-0.50-2.84-2.16
R&D Expense 420.57K347.13K459.09K589.87K733.64K780.33K1.13M1.40M1.68M1.91M2.19M1.81M1.58M1.49M1.02M

Balance Sheet (Annual)

Figures in USD.

Metric May 2010May 2011May 2012May 2013May 2014May 2015May 2016May 2017May 2018May 2019May 2020May 2021May 2022May 2023May 2024May 2025
Total Assets -4.96M5.57M6.39M6.47M6.12M5.73M5.02M5.22M5.25M17.26M11.82M11.37M14.45M9.25M5.95M
Total Equity 4.06M4.33M4.98M5.83M5.91M5.60M5.22M4.49M4.33M3.98M14.21M9.23M8.32M11.72M6.59M4.11M
Cash & Equivalents 1.06M989.27K1.08M2.47M1.51M1.09M1.89M1.23M1.20M686.78K8.64M4.20M5.92M9.72M4.17M2.40M
Total Liabilities ---------1.26M3.05M2.59M3.05M2.73M2.66M1.84M
Current Liabilities -625.01K592.29K559.89K555.84K523.93K506.03K528.87K896.81K1.26M1.48M1.30M2.01M1.95M2.20M1.74M

Cash Flows (Annual)

Figures in USD.

Metric May 2011May 2012May 2013May 2014May 2015May 2016May 2017May 2018May 2019May 2020May 2021May 2022May 2023May 2024May 2025
Operating Cash Flow 328.80K147.41K1.39M-862.27K-405.48K-208.78K-722.86K-1.17M-2.24M-4.30M-5.25M-479.00K-5.47M-5.36M-3.84M
Investing Cash Flow -431.68K-113.17K-257.12K-282.53K-22.78K-95.19K-96.08K-130.35K-171.11K-118.93K-295.58K-170.00K-78.00K-115.00K-37.00K
Financing Cash Flow 37.89K55.40K258.51K185.28K9.56K1.11M157.73K1.29M1.91M12.37M1.11M2.39M9.39M-81.00K2.11M
Capital Expenditure -141.08K-164.80K-257.12K-137.23K-10.50K-91.56K-96.08K-130.35K-101.14K-33.61K-135.86K-57.00K-64.00K-51.00K-
Free Cash Flow 187.72K-17.39K1.14M-999.51K-415.98K-300.34K-818.94K-1.30M-2.35M-4.33M-5.39M-536.00K-5.54M-5.41M-

Ratios (Annual)

Figures in %.

Metric May 2011May 2012May 2013May 2014May 2015May 2016May 2017May 2018May 2019May 2020May 2021May 2022May 2023May 2024May 2025
Gross Margin % 31.1%37.8%37.5%32.6%31.1%29.7%34.9%31.5%24.8%26.6%5.1%15.8%8.4%11.3%9.4%
Operating Margin % -2.7%8.3%7.9%-8.7%-13.5%-16.1%-16.5%-26.6%-46.4%-35.9%-104.2%-24.0%-135.3%-117.6%-96.7%
Net Margin % 3.2%9.0%8.3%-4.2%-6.7%-29.2%-15.7%-26.3%-46.0%-34.9%-103.4%-24.0%-133.7%-110.4%-93.6%
ROE % 3.6%11.0%9.2%-3.6%-5.9%-28.7%-20.2%-33.9%-60.1%-16.5%-80.7%-54.4%-60.9%-90.7%-121.1%
ROCE % -3.1%10.1%8.8%-7.6%-12.0%-15.8%-21.3%-34.3%-60.6%-15.2%-71.3%-48.4%-57.7%-90.3%-122.2%

Shareholding Pattern

Insiders
15.24%
Institutions
3.62%
Public Float
4.27%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BMRA

Google News Fri, 31 Jul 2026

BMRA|Biomerica Inc|Price:1.490|Chg%:-0.050 - TradingKey

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1La3dBbjJSUDRpbkxfYXN5YVg4bHlUaWpiaUtqYU4tRVJPZGVIRkg2M0N2WWhpMXM5SjREYU5DZlNZRGlDcW5wTUZ3X29Jb21GVVRVTHhrT09rQQ?oc=5" target="_blank">BMRA|Biomerica Inc|Price:1.490|Chg%:-0.050</a…

Google News Fri, 24 Jul 2026

Biomerica, Inc. Revenue Breakdown – NASDAQ:BMRA - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE8tNXozaE1PSndUUUFGR09QaDA1a0JGaWdyS1g1S1FaSEMxWnRFMGFiM1p1dVAtUmxiUTFhbTNoT1NjbWZZRVpxallQb3VNaTJmNWFGMG9XNC03MEhLbldDWHBlZlFiV00zalh5cWY1ODBQeG5lWHFB?oc=5" target="_blank">Biomeri…

Google News Sun, 31 Mar 2024

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE5DeWR1MWhtaS1kQ0VLTGNoTkVFSWlVNzRrcUtSVzVmcTROVi10OWJNWTNhb29fakNVbUNDX3duTkJQNlpJOTBfbFFlNklLQzQz?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>&nbsp;&nbsp;<fon…

Google News Sun, 16 Nov 2025

Biomerica Inc. (BMRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

<a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTFBqcllRWmEyTUgxTnMzNmlvZmNrNUE5ekJHbTBRYXNVZkNvSFZJcEY3cUVyQVpkcnlQMDdNU05CaDhzWG1KRl9rTm5iN0dkUQ?oc=5" target="_blank">Biomerica Inc. (BMRA) Stock Price | Live Quotes & Charts | NA…

Google News Sun, 02 Aug 2026

BMRA Q2 2026 Earnings: Loss of $0.44 Per Share Amid Thin Disclosure - Earnings Miss Alert - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTW5GRHdmN3pfeFBUa1pxaFNrZkhqR3RDbHUyVk9CUl9NV25abHhhNUpyblBwUU1oX3FURUpzSXNjQ1lkc0pPMXdrcFVBXzY3eGdhdlJoU01sTDZGMTUzZVE3S0F6dlJ1bXM0OTg2QzBsX3hNUVRpa1djb2FJekhYdTVfR2ZkdTE0aWFMTT…

Google News Sun, 26 Jul 2026

BMRA|Biomerica Inc|Price:1.530| - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9wSmozSEV4OG1rbXpBdzIzOVY5YlVpYlEwYzFlamkyeTE3UEk2RXBTa0lleTFjTXZhOXFGTW9Nd3JsV0xJY25tbVhkRG9vb25ycHU5cWJ1TnJjeEF1dnZCUmEzQ1BtMS1BMGxRY2FR?oc=5" target="_blank">BMRA|Biomerica Inc|…

BMRA — Frequently Asked Questions

What is the current share price of BMRA?

As of 2026-08-05 17:25 PDT, BMRA trades at $1.62 on NASDAQ/NYSE. Its 52-week range is $1.49 to $3.51.

What is the P/E ratio of BMRA?

BMRA trades at a trailing price-to-earnings (P/E) ratio of -0.75.

What is the return on equity (ROE) of BMRA?

BMRA has a return on equity (ROE) of -121.14%. Its return on capital employed (ROCE) is -122.16%.

Is BMRA a good stock to buy?

This page provides a data-driven analysis of BMRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks